Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers - Lundström - 2021 - Journal of Medical Virology - Wiley Online Library
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Frontiers | Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
Angiotensin-converting enzyme in innate and adaptive immunity | Nature Reviews Nephrology
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice - ScienceDirect
Angiotensin and the Coronavirus | Science | AAAS
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension
Angiotensin-converting enzyme - Wikipedia
Angiotensin-converting enzyme 2 - Wikipedia
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
Do Studies With ACE N- and C-Domain–Selective Inhibitors Provide Evidence for a Non-ACE, Non-Chymase Angiotensin II–Forming Pathway? | Circulation Research
Frontiers | Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters | Bentham Science
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment: Molecular Therapy - Methods & Clinical Development
What Is an Angiotensin Converting Enzyme Inhibitor? | Circulation
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
SARS-CoV-2 Infection & Cardiology: Overview on Renin-Angiotensin-Aldosterone System Inhibition
Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors | PLOS ONE
ACE inhibitor - Wikipedia
ACE and ACE2 in Inflammation: A Tale of Two Enzymes | Bentham Science
An ACE structure | Nature Structural & Molecular Biology
Cancers | Free Full-Text | Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions
Angiotensin-konvertierendes Enzym aus Kaninchenlunge ≥2.0 units/mg protein (modified Warburg-Christian) | Sigma-Aldrich
